Mumbai, Aug. 5 -- The growth in revenue was driven by strong performance in Europe and other growth markets.

Profit before tax (PBT) fell 8.8% YoY to Rs 1,206.80 crore in Q1 FY26.

EBITDA before forex and other income stood at Rs 1,603 crore, down 1% YoY. EBITDA margin reduced by 102 bps on YoY basis to 20.4% in the quarter ended June 2025.

In the first quarter, US formulation revenue marginally decreased by 1.9% YoY to Rs 3,488 crore and accounted for 44.3% of consolidated revenue. Europe formulation revenue increased by 18% YoY to Rs 2,338 crore and accounted for 29.7% of consolidated revenue.

Growth Markets formulations revenue increased by 8.8% YoY to Rs 772 crore, driven by good performance in key markets and accounted for 9.8% of...